Biliary cirrhosis is a chronic condition characterised by the progressive destruction of the bile ducts within the liver. This destruction hampers bile transport, a fluid essential for absorbing fats and fat-soluble vitamins in the small intestine.
The accumulation of bile leads to inflammation and scarring (fibrosis) in the liver, which can progress to cirrhosis, where normal liver tissue is replaced by scar tissue, severely impacting liver function.
This condition is categorised into two main types: primary biliary cirrhosis (PBC) and secondary biliary cirrhosis (SBC). The causes and risk factors vary significantly between both types.
PBC is primarily considered an autoimmune condition, though its exact cause remains unclear. Key factors include:
SBC results from conditions that cause prolonged obstruction of the bile ducts, leading to bile accumulation and liver damage. Common causes include:
Apart from the direct causes, several risk factors increase the likelihood of developing biliary cirrhosis:
Biliary cirrhosis can progress asymptomatically, often presenting no symptoms until the condition is in an advanced stage. When symptoms do appear, they may include:
Fatigue: A pervasive sense of tiredness that is not relieved by rest
Itching (Pruritus): Unexplained, persistent itching, typically without a rash, affecting various body parts.
Dry eyes and mouth: Symptoms that are part of the sicca syndrome, which can be associated with autoimmune disorders.
Diagnosing biliary cirrhosis involves a combination of clinical evaluation, laboratory tests, and imaging studies to assess liver function and structure.
Additional diagnostic procedures may be recommended to rule out other conditions or confirm the diagnosis, such as endoscopic retrograde cholangiopancreatography (ERCP), which visualises the bile and pancreatic ducts more directly.
Understanding the available treatment options for biliary cirrhosis aids in managing the condition and improving patient outcomes.
Non-surgical treatments focus on medication and lifestyle adjustments to manage symptoms and slow disease progression.
Surgical treatments and procedures, including biliary drainage and liver transplantation, are considered for advanced cases or when non-surgical options are insufficient.
As the disease progresses, several complications may arise.
Increased blood pressure in the portal vein system could lead to varices and an increased risk of bleeding.
A severe reduction in liver function can lead to life-threatening complications.
Cirrhosis elevates the risk of developing liver cancer.
Reduced bone density, making bones more fragile and prone to fractures.
MBBS(新加坡)• MMed(外科)• MRCS(爱尔兰)• FRCSEd(普通)• FAMS(外科)
唐永贤医生是一位接受过专科培训的肝胆胰外科及普通外科医生,已完成超过6000例外科手术。.
他首先在新加坡中央医院肝胆外科接受了肝胆外科的专科培训。之后,他在韩国首尔大学医院盆唐分院完成了微创肝胆外科的临床研究员培训。.
唐医生在其所在的医院创建并率先开展了微创手术项目,用于治疗复杂的肝脏和胰腺疾病。他的手术曾多次在国家电视台进行现场直播。他的手术视频也曾在国际外科会议上展出。此外,他还率先将胶囊内镜应用于结直肠癌筛查。.
Thng医生曾在医院、医疗集群和卫生部等多个委员会任职。Thng医生曾担任卫生部以价值为导向的医疗服务(VDC)腹腔镜胆囊切除术临床医生工作组成员。.
医疗保健的财务问题可能令人不知所措。让我们协助您处理保险理赔事宜,使您能够专注于康复。我们诊所友好的工作人员随时准备解答您关于保险或付款方式的任何疑问。.
精准外科中心 @ 鹰阁医院附属楼
如果您出现相关症状或想了解您的治疗方案,请立即联系我们。.